(GBTG) Global Business Travel - Overview
Stock: Travel Platform, Consulting, Meetings, Outsourced Services, Expense Management
| Risk 5d forecast | |
|---|---|
| Volatility | 57.3% |
| Relative Tail Risk | -7.63% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.12 |
| Alpha | -55.66 |
| Character TTM | |
|---|---|
| Beta | 1.085 |
| Beta Downside | 1.009 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.57% |
| CAGR/Max DD | -0.21 |
Description: GBTG Global Business Travel January 08, 2026
Global Business Travel Group, Inc. (GBTG) operates a technology-driven B2B travel platform across the United States, United Kingdom and other international markets, connecting corporate travelers, travel suppliers and third-party agencies through a suite of digital solutions.
The company’s product portfolio includes the Amex GBT Egencia digital booking tool, Neo spend-management platform, Neo customizable travel suite, Select analytics-focused solution, and Ovation personalized service, all designed to streamline end-to-end business-travel logistics and expense control.
In FY 2023 GBTG reported roughly $1.2 billion in revenue, a modest 5 % year-over-year increase driven by the rebound in corporate travel spend and higher adoption of its spend-management tools; adjusted EBITDA margin hovered around 4 %, reflecting ongoing investment in platform integration and data analytics.
Key macro drivers for the sector include a projected 6 % compound annual growth rate in global corporate travel spend through 2028, accelerated digitization of expense management, and the consolidation of travel-supplier data via APIs, which GBTG leverages to differentiate its offering.
For a deeper quantitative comparison of GBTG’s valuation metrics, you might explore the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 10.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.77 > 1.0 |
| NWC/Revenue: 11.92% < 20% (prev 21.08%; Δ -9.16% < -1%) |
| CFO/TA 0.05 > 3% & CFO 246.0m > Net Income 10.0m |
| Net Debt (1.05b) to EBITDA (379.0m): 2.77 < 3 |
| Current Ratio: 1.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (485.8m) vs 12m ago 5.09% < -2% |
| Gross Margin: 61.03% > 18% (prev 0.59%; Δ 6043 % > 0.5%) |
| Asset Turnover: 59.14% > 50% (prev 63.46%; Δ -4.32% > 0%) |
| Interest Coverage Ratio: 2.23 > 6 (EBITDA TTM 379.0m / Interest Expense TTM 93.0m) |
Altman Z'' -0.86
| A: 0.06 (Total Current Assets 1.62b - Total Current Liabilities 1.32b) / Total Assets 4.76b |
| B: -0.33 (Retained Earnings -1.55b / Total Assets 4.76b) |
| C: 0.05 (EBIT TTM 207.0m / Avg Total Assets 4.26b) |
| D: -0.51 (Book Value of Equity -1.64b / Total Liabilities 3.23b) |
| Altman-Z'' Score: -0.86 = CCC |
Beneish M -2.72
| DSRI: 1.37 (Receivables 1.09b/751.0m, Revenue 2.52b/2.38b) |
| GMI: 0.97 (GM 61.03% / 59.39%) |
| AQI: 1.06 (AQ_t 0.58 / AQ_t-1 0.55) |
| SGI: 1.06 (Revenue 2.52b / 2.38b) |
| TATA: -0.05 (NI 10.0m - CFO 246.0m) / TA 4.76b) |
| Beneish M-Score: -2.72 (Cap -4..+1) = A |
What is the price of GBTG shares?
Over the past week, the price has changed by -17.81%, over one month by -32.64%, over three months by -28.24% and over the past year by -37.33%.
Is GBTG a buy, sell or hold?
- StrongBuy: 6
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GBTG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10.9 | 97.8% |
| Analysts Target Price | 10.9 | 97.8% |
| ValueRay Target Price | 5.3 | -3.5% |
GBTG Fundamental Data Overview February 03, 2026
P/E Forward = 10.989
P/S = 1.4407
P/B = 2.3968
Revenue TTM = 2.52b USD
EBIT TTM = 207.0m USD
EBITDA TTM = 379.0m USD
Long Term Debt = 1.37b USD (from longTermDebt, last quarter)
Short Term Debt = 45.0m USD (from shortTermDebt, last quarter)
Debt = 1.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.05b USD (from netDebt column, last quarter)
Enterprise Value = 4.67b USD (3.63b + Debt 1.48b - CCE 427.0m)
Interest Coverage Ratio = 2.23 (Ebit TTM 207.0m / Interest Expense TTM 93.0m)
EV/FCF = 37.70x (Enterprise Value 4.67b / FCF TTM 124.0m)
FCF Yield = 2.65% (FCF TTM 124.0m / Enterprise Value 4.67b)
FCF Margin = 4.93% (FCF TTM 124.0m / Revenue TTM 2.52b)
Net Margin = 0.40% (Net Income TTM 10.0m / Revenue TTM 2.52b)
Gross Margin = 61.03% ((Revenue TTM 2.52b - Cost of Revenue TTM 981.0m) / Revenue TTM)
Gross Margin QoQ = 59.94% (prev 61.65%)
Tobins Q-Ratio = 0.98 (Enterprise Value 4.67b / Total Assets 4.76b)
Interest Expense / Debt = 1.63% (Interest Expense 24.0m / Debt 1.48b)
Taxrate = 21.0% (US default 21%)
NOPAT = 163.5m (EBIT 207.0m * (1 - 21.00%))
Current Ratio = 1.23 (Total Current Assets 1.62b / Total Current Liabilities 1.32b)
Debt / Equity = 0.96 (Debt 1.48b / totalStockholderEquity, last quarter 1.53b)
Debt / EBITDA = 2.77 (Net Debt 1.05b / EBITDA 379.0m)
Debt / FCF = 8.45 (Net Debt 1.05b / FCF TTM 124.0m)
Total Stockholder Equity = 1.23b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.23% (Net Income 10.0m / Total Assets 4.76b)
RoE = 0.82% (Net Income TTM 10.0m / Total Stockholder Equity 1.23b)
RoCE = 7.99% (EBIT 207.0m / Capital Employed (Equity 1.23b + L.T.Debt 1.37b))
RoIC = 6.27% (NOPAT 163.5m / Invested Capital 2.61b)
WACC = 7.42% (E(3.63b)/V(5.10b) * Re(9.91%) + D(1.48b)/V(5.10b) * Rd(1.63%) * (1-Tc(0.21)))
Discount Rate = 9.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.99%
[DCF Debug] Terminal Value 72.98% ; FCFF base≈140.0m ; Y1≈91.9m ; Y5≈41.9m
Fair Price DCF = N/A (negative equity: EV 915.5m - Net Debt 1.05b = -132.5m; debt exceeds intrinsic value)
EPS Correlation: 28.73 | EPS CAGR: 11.69% | SUE: 0.13 | # QB: 0
Revenue Correlation: 79.99 | Revenue CAGR: 25.57% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.14 | Chg30d=-0.004 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=0.43 | Chg30d=-0.013 | Revisions Net=-1 | Growth EPS=-10.2% | Growth Revenue=+19.8%